Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.
High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.
Pharmacists’ pharmacotherapeutic expertise helps them advocate for their patients and assist providers.
Pharmacy managers must not only possess high levels of emotional intelligence, but should also encourage development among staff that facilitates more effective and creative outlets for frustration.
The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.
Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.
Taking a few seconds to double-check a prescription can have significant impacts on patient safety
Pharmacists can play a key role in providing education and guidance to patients with glaucoma.
Integrating immunotherapies will continue to improve patient outcomes and quality of life.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
The combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.
Challenges remain, however, to therapy development for a limited patient population.
How patients acquire NSCLC plays a role in health outcomes, with never-smoker patients having genetically different disease than the same disease in smokers.
Texting with patients can help to improve pharmacy processes while creating better user experiences.
Gene therapies in late-stage development may soon provide hope for a cure.
With more work and less staff, we need to examine how we can better support pharmacists in the new normal brought on by COVID-19.
In January 2024, Florida became the only state to allow the importation of medications for public use.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Professional assistance programs provide pathway for health care professionals to return to practice following treatment for substance use disorder.
Pharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
The relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.
The exciting therapies in the pipeline that are thought to target novel mechanisms in Waldenström macroglobulinemia.
Duration of therapy may be just 5 to 6 days for patients without risk factors for complications.
This vaccine rollout has become even more crucial for the US health care system, as new mutations of the coronavirus continue to emerge.
Insurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.
Hospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.